{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:29:45Z","timestamp":1778275785673,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":4352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1046\/j.1469-0691.2003.00564.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:28:30Z","timestamp":1047367710000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors"],"prefix":"10.1016","volume":"9","author":[{"given":"J.S.","family":"Oxford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Balasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lambkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00564.x_bib1","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1001\/jama.1993.03510160074032","article-title":"Clinical effectiveness of influenza vaccination in Manitoba","volume":"270","author":"Fedson","year":"1993","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib2","series-title":"Influenza","author":"Mulder","year":"1972"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib3","series-title":"The pathology of influenza","author":"Winternitz","year":"1920"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib4","series-title":"Influenza, the viruses and the disease","author":"Stuart-Harris","year":"1983"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-ada mantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib6","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003088-198814010-00003","article-title":"Clinical pharmacokinetics of amantadine hydrochloride","volume":"14","author":"Aoki","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib8","first-page":"169","article-title":"Anti influenza virus activity of amantadine","volume":"1","author":"Oxford","year":"1984","journal-title":"Viral Chemother"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJM200011023431801","article-title":"Inhaled zanamivir for the prevention of influenza in families","volume":"343","author":"Hayden","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0166-3542(89)90018-1","article-title":"Efficacy and safety of low dose amantadine hydrochloride as prophylaxis for influenza A","volume":"11","author":"Reuman","year":"1989","journal-title":"Antiviral Res"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/226082a0","article-title":"In vivo selection of an influenza A2 strain resistant to amantadine","volume":"226","author":"Oxford","year":"1970","journal-title":"Nature Lond"},{"issue":"9","key":"10.1046\/j.1469-0691.2003.00564.x_bib13","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.1970.03170350016003","article-title":"Evaluation of amantadine in artificially induced A2 and B influenza","volume":"213","author":"Smorodintsev","year":"1970","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.23.4.577","article-title":"Reduction in fever in young adults with influenza A\/Brazil 78, H1, N1 infection after treatment with aspirin or amantadine","volume":"23","author":"Younkin","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1046\/j.1469-0691.2003.00564.x_bib15","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.31.10.1470","article-title":"Protective efficacy of low dose amantadine in adults challenged with wild-type influenza A virus","volume":"31","author":"Sears","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-2836(64)80094-2","article-title":"Structural studies on the protein subunits from three strains of influenza virus","volume":"9","author":"Laver","year":"1964","journal-title":"J Mol Biol"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase","volume":"303","author":"Colman","year":"1983","journal-title":"Nature"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1515\/bchm2.1969.350.2.1088","volume":"350","author":"Meindl","year":"1969","journal-title":"Hoppe Seyler's Z Physiol Chem"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"Von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/scientificamerican0199-78","article-title":"Disarming flu viruses","volume":"280","author":"Laver","year":"1999","journal-title":"Scientific Am"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo","volume":"55","author":"Ives","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"Gubareva","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1046\/j.1469-0691.2003.00564.x_bib23","doi-asserted-by":"crossref","first-page":"A73","DOI":"10.1016\/S0166-3542(97)83251-2","article-title":"GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B virus in vitro","volume":"34","author":"Mendel","year":"1997","journal-title":"Antiviral Res"},{"issue":"14","key":"10.1046\/j.1469-0691.2003.00564.x_bib24","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0960-894X(99)00318-2","article-title":"Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping","volume":"9","author":"Brouillette","year":"1999","journal-title":"Bioorganic Med Cem Lett"},{"issue":"suppl 1","key":"10.1046\/j.1469-0691.2003.00564.x_bib25","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1086\/514178","article-title":"Design of aromatic inhibitors of influenza virus neuraminidase","volume":"176","author":"Luo","year":"1997","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1046\/j.1469-0691.2003.00564.x_bib26","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/jm980162u","article-title":"Structure\u2013activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors","volume":"41","author":"Kim","year":"1998","journal-title":"J Med Chem"},{"issue":"4","key":"10.1046\/j.1469-0691.2003.00564.x_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jama.1996.03530280047035","article-title":"Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza","volume":"275","author":"Hayden","year":"1996","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/jinf.1999.0602","article-title":"Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomised, double-blind, placebo-controlled European study","volume":"40","author":"Makela","year":"2000","journal-title":"J Infect"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/314904","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections","volume":"180","author":"Monto","year":"1999","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1046\/j.1469-0691.2003.00564.x_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1359-6446(98)01241-0","article-title":"Targeting influenza virus neuraminidase\u2014a new strategy for antiviral therapy","volume":"3","author":"Oxford","year":"1998","journal-title":"Drug Discovery Today"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib32","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib34","series-title":"Influenza: a race against time","author":"Oxford","year":"2001"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib35","first-page":"147","article-title":"Response to a pandemic of influenza: an action plan","volume":"10","author":"Public Health Laboratory Service","year":"1993","journal-title":"PHLS Digest"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<119::AID-RMV272>3.0.CO;2-O","article-title":"InfluenzaApandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology","volume":"10","author":"Oxford","year":"2000","journal-title":"Rev Med Virol"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3201\/eid0505.990507","article-title":"The economic impact of pandemic influenza in the United States: priorities for intervention","volume":"5","author":"Meltzer","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib38","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.96.4.1651","article-title":"Origin and evolution of the 1918 Spanish influenza virus haemagglutinin gene","volume":"96","author":"Reid","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1469-0691.2003.00564.x_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1520\/JFS14642J","article-title":"Ground penetrating radar survey to locate 1918 Spanish flu victims in permafrost","volume":"20","author":"Davis","year":"2000","journal-title":"J Forensic Sci"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14638325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14638325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:17:59Z","timestamp":1761117479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14638325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S1198743X14638325"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00564.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00564.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}